Soleus Capital Management, L.P. Novo Cure LTD Transaction History
Soleus Capital Management, L.P.
- $1.21 Billion
- Q1 2025
A detailed history of Soleus Capital Management, L.P. transactions in Novo Cure LTD stock. As of the latest transaction made, Soleus Capital Management, L.P. holds 5,521,414 shares of NVCR stock, worth $96.2 Million. This represents 8.14% of its overall portfolio holdings.
Number of Shares
5,521,414
Previous 2,739,704
101.53%
Holding current value
$96.2 Million
Previous $81.6 Million
20.51%
% of portfolio
8.14%
Previous 5.68%
Shares
18 transactions
Others Institutions Holding NVCR
# of Institutions
266Shares Held
79.3MCall Options Held
970KPut Options Held
118K-
Black Rock Inc. New York, NY12.1MShares$211 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.3MShares$196 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA8.95MShares$156 Million0.03% of portfolio
-
Capital World Investors Los Angeles, CA5.22MShares$90.9 Million0.02% of portfolio
-
State Street Corp Boston, MA2.59MShares$45.1 Million0.0% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $1.83B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...